genetic diagnostics
genetic tests
attractive genetic diagnostic market
sequencing technology platform
unique diagnostic technology
personalized treatment of cancer
relevant genetic variants
genetic variants relevant
generation sequencing
global diagnostic
types of genetic variants
customizable companion diagnostic kit
vitro companion diagnostic kits
targeted NGS sequencing of complete genes
personalized treatment of breast
companion diagnostics
vitro companion diagnostic BRCA SEQURE kit
adoption of personalized medicine
complete sequence of genes
cost-effective technology
personalized treatment of oncologic disorders
pharmaceutical company
SEQURE project
sequencing of short fragments
complete sequence information
Dutch biotechnology company Cergentis
structural changes
platform development
unmet need
ovarian cancer
Targeted Locus Amplification
proprietary TLA
gene fusions
gene regions
pharmaceutical companies
current tests
effectiveness of drug development
oncology clinical trials
high growth potential biotechnology SME
effective large scale clinical implementation
analysis of tumor biopsies
co-licensing agreement
diagnosis
detection
introns
fraction
forefront
commercialization
single rapid analytical procedure
exons
lab
therapeutic decisions
gap
validation